ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2019

Audio

Listen to expert commentary on the clinical impact of data from the Vienna meeting regarding treatment of viral hepatitis and progress toward HCV elimination.

Released: May 10, 2019

Expiration: May 08, 2020

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

Gilead

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief Internal Medicine
Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, Intercept, and Merck and fees for non-CME/CE services from AbbVie, Gilead Sciences, Janssen, and Merck.